Screening and Treatment for Sex Workers
Sex workers should receive comprehensive STI screening at baseline including chlamydia, gonorrhea, syphilis, HIV, hepatitis B and C at all exposed anatomical sites (genital, rectal, pharyngeal), followed by regular screening every 3 months, with presumptive treatment for chlamydia, gonorrhea, and trichomoniasis at the initial visit. 1, 2
Screening Protocol
Initial Visit - Comprehensive Testing
- NAATs for chlamydia and gonorrhea at ALL sites of potential exposure:
- Vaginal/cervical specimens
- Rectal specimens (even without reported receptive anal sex)
- Pharyngeal specimens
- Syphilis serology (RPR or VDRL with confirmatory testing)
- HIV testing (4th generation antigen/antibody test preferred)
- Hepatitis B surface antigen (HBsAg)
- Hepatitis C antibody with reflex RNA if positive
- Trichomoniasis via NAAT from urine or vaginal specimen
- Pregnancy test for reproductive-aged individuals 1, 2, 3
Follow-up Screening Frequency
- Every 3 months for chlamydia, gonorrhea, syphilis, and HIV in sexually active sex workers
- More frequent screening (monthly) may be warranted for those with known high-risk exposures or in high-prevalence communities 2, 4
Treatment Approach
Presumptive Treatment at Initial Visit
Given poor follow-up compliance and high baseline STI prevalence (70-80% in some populations), immediate empiric treatment is essential 1, 5:
Ceftriaxone 250 mg IM single dose
- (500 mg if body weight >150 kg per 2021 updates) 6
PLUS
Doxycycline 100 mg orally twice daily for 7 days
- (Preferred over azithromycin for chlamydia per 2021 guidelines) 6
PLUS
Metronidazole 500 mg orally twice daily for 7 days
- (Preferred over single 2g dose for trichomoniasis per 2021 updates) 6
Vaccination at Initial Visit
- Hepatitis B vaccine series if not previously vaccinated (0,1-2 months, 6 months)
- HPV vaccine if age ≤26 years (0,1-2 months, 6 months) 1
HIV Prevention
- Discuss and offer HIV PEP if recent high-risk exposure within 72 hours
- Offer HIV PrEP for ongoing risk reduction 1, 2
Critical Pitfalls to Avoid
Multi-site testing is non-negotiable: Extragenital infections (rectal, pharyngeal) are frequently asymptomatic and missed if only genital specimens are collected. Up to 30-40% of gonorrhea and chlamydia infections in high-risk populations are extragenital only 3.
Don't wait for test results: The evidence strongly supports presumptive treatment at the first visit because follow-up rates are typically <50% in this population 1, 5, 4. Treating empirically prevents complications and ongoing transmission.
Syphilis screening threshold: In communities with primary/secondary syphilis rates >4.6 per 100,000 (per Healthy People 2030 goals), screen at every visit. Many urban areas exceed this threshold 3.
Test-of-cure requirements:
- Always retest pharyngeal gonorrhea 7-14 days after treatment (high treatment failure rates)
- Retest rectal chlamydia if treated with azithromycin (though doxycycline is now preferred) 6
Ongoing Care Structure
Follow-up Visits Every 3 Months
- Repeat full STI screening panel
- Risk-based treatment rather than routine presumptive treatment if:
Essential Non-Clinical Components
The evidence emphasizes that clinical services alone are insufficient. Effective programs integrate 5, 4, 7:
- Peer education and empowerment
- Access to condoms and safer sex supplies
- Linkage to housing, food security, and insurance resources
- Non-judgmental, anti-racist providers vetted by sex worker community
- Substance use treatment services when needed
Evidence Strength
The 2015 CDC STI Treatment Guidelines 1 provide the foundational framework, with important updates from 2021 guidelines 6 regarding treatment regimens. The USPSTF recommendations 8 support intensive screening for high-risk populations. Recent evidence 2 from 2025 confirms that sex workers remain a priority population for regular screening every 3 months. The implementation research 5, 4 demonstrates that combining regular screening with presumptive treatment and peer support achieves the best outcomes in resource-limited settings where sex workers have limited healthcare access.